Neuroone Medical Technologies (NMTC) Return on Capital Employed (2011 - 2026)
Neuroone Medical Technologies posted quarterly Return on Capital Employed of 108.18% for Q1 2026, up 6906.0% year-on-year from 1.54% in Q1 2025, and down 19.19% on a QoQ basis from 90.76% in Q4 2025.
Neuroone Medical Technologies (NMTC) has 15 years of Return on Capital Employed data on file, last reported at 108.18% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed rose 6906.0% year-over-year to 108.18%; the trailing twelve-month figure through Mar 2026 stood at 108.18% (up 6906.0% YoY), and the FY2025 full-year result was 73.19%, up 18978.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 108.18%, down from 90.76% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 49.73% in Q3 2025 and bottomed at 405.98% in Q3 2024.
- The 5-year median for Return on Capital Employed is 137.19% (2023), against an average of 173.64%.
- The widest annual swing landed in 2024, when Return on Capital Employed plunged 18117 bps; it then jumped 35625 bps in 2025.
- A 5-year view of Return on Capital Employed shows it stood at 90.91% in 2022, then sank by 168 bps to 243.18% in 2023, then soared by 36 bps to 155.59% in 2024, then soared by 42 bps to 90.76% in 2025, then retreated by 19 bps to 108.18% in 2026.
- The last three Return on Capital Employed figures came in at 108.18% (Q1 2026), 90.76% (Q4 2025), and 49.73% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn | -108.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -108.18% |
| Dec 31, 2025 | -90.76% |
| Sep 30, 2025 | -49.73% |
| Jun 30, 2025 | -91.31% |
| Mar 31, 2025 | -177.24% |
| Dec 31, 2024 | -155.59% |
| Sep 30, 2024 | -405.98% |
| Jun 30, 2024 | -353.33% |
| Mar 31, 2024 | -318.36% |
| Dec 31, 2023 | -243.18% |
| Sep 30, 2023 | -232.81% |
| Jun 30, 2023 | -215.28% |
| Mar 31, 2023 | -137.19% |
| Dec 31, 2022 | -90.91% |
| Sep 30, 2022 | -110.25% |
| Jun 30, 2022 | -93.84% |
| Mar 31, 2022 | -77.89% |
| Dec 31, 2021 | -94.66% |
| Sep 30, 2021 | -132.84% |
| Jun 30, 2021 | -76.03% |
| Mar 31, 2021 | -68.20% |
| Dec 31, 2020 | -3,400.69% |
| Sep 30, 2020 | -217.38% |
| Jun 30, 2020 | 120.11% |
| Mar 31, 2020 | 150.20% |
| Dec 31, 2019 | 121.84% |
| Sep 30, 2019 | 803.13% |
| Jun 30, 2019 | -2,298.62% |
| Mar 31, 2019 | 823.92% |
| Jun 30, 2018 | 128.44% |
| Mar 31, 2018 | 76.80% |
| Dec 31, 2017 | 84.26% |
| Dec 31, 2016 | 70.73% |
| Sep 30, 2016 | 34.13% |
| Jun 30, 2016 | 29.68% |
| Mar 31, 2016 | 40.68% |
| Jun 30, 2014 | 139.77% |
| Mar 31, 2014 | 773.41% |
| Dec 31, 2013 | 82.95% |
| Sep 30, 2013 | 85.48% |
| Jun 30, 2013 | 100.46% |
| Mar 31, 2013 | 58.15% |
| Dec 31, 2012 | 81.53% |
| Sep 30, 2012 | 2,713.91% |
| Jun 30, 2012 | -1,122.04% |
| Mar 31, 2012 | -410.16% |
| Dec 31, 2011 | -577.19% |
| Sep 30, 2011 | 633.77% |